期刊文献+

胆囊结石病人成纤维细胞生长因子-19的血浆含量及胆囊黏膜表达特点 被引量:1

Fibroblast growth factor-19 in gallstone patients:plasma content and expression of gallbladder mucosa characteristics
下载PDF
导出
摘要 目的:检测胆囊结石病人成纤维生长因子-19(fibroblast growth factor-19,FGF-19)的血浆含量及其在胆囊黏膜的表达量.探讨FGF-19与胆囊舒张收缩功能的关系。方法:对27例胆囊结石病人(男9例,女18例,平均年龄48.5岁1。采用实时定量PCR法检测胆囊黏膜彤F-19mRNA的表达量。采用酶联免疫吸附法测定空腹及脂餐后1.5h、3.0h血浆FGF-19的含量。B超检查胆囊收缩功能。结果:按脂餐后1.5h胆囊排空率(ejectionfraction.EF)将胆石病人分为胆囊收缩正常组fEF〉60%,n=5),收缩减弱组[EF(30~60)%,n=15]和未收缩组(EF〈30%,n=7),3组餐后1.5h的胆囊EF分别为(67.2±3.4)%,(48.2±2.4)%和(17.0+3.5)%,P〈0.01。收缩正常组的胆囊再充盈率[(82±12)%1大于收缩减弱组与未收缩组[(37±11)%和(7±71%1,P=O.006。未收缩组的胆囊黏膜凡;F-19mRNA表达量(130±711显著低于收缩正常组与收缩减弱组(222±82,254±50),P〈0.05。未收缩组空腹血浆FGF.19含量[(62.1±20.O)pg/mL]显著低于其他两组『收缩正常组(157.9±22.3)pg/mL,收缩减弱组(175.8±25.6)pg/mL],P〈O.05。结论:部分胆石病人存在胆囊收缩和舒张功能障碍。血浆FGF-19含量变化可反映胆囊收缩和舒张功能异常。 Objective To evaluate the relation between fibroblast growth factor (FGF)-19 and gallbladder motility function by measuring the serum level of FGF-19 and the expression of FGF-19 mRNA in gallbladder mucosa from patients with gallstone disease. Methods Nine male and 18 female patients with gallstone disease were recruited. FGF- 19 mRNA expressions in gallbladder mucosa were determined by real-time PCR. Plasma FGF-19 level at fasting, 1.5 h and 3.0 h after fat diet were assayed by ELISA, the gallbladder volume at the corresponding time points were measured by B-type ultrasonic scanning. Results According to gallbladder ejection fraction (EF) at 1.5 h after fat diet, the patients were divided into 3 groups. For normal contraction group (EF 〉 60%, n= 5), low contraction group [EF (30 - 60)%, n=15] and non contraction group (EF 〈 30%, n=7), EF at 3.0 h after fat-diet were (67.2±3.4)%, (48.2±2.4)%, and (17.0±3.5)%, respectively, P 〈 0.01. Gallbladder refilling rate in normal contraction group (82+-12)% was higher than low contraction and non contraction group [(37±11)% and (7±7)%], P = 0.006. FGF-19 mRNA expression in gallbladder mucosa was significantly lower in the non contraction group (130±71) than in the normal contraction group and the low contraction group (222±82 and 254±50), P〈0.05. Fasting plasma FGF-19 level in non contraction group [(62.1±20.0) pg/mL] was lower than the other groups[normal contraction group:(157.9±22.3) pg/mL], low contraction group: [(175.8±25.6) pg/mL], P〈 0.05. Conclusions Gallbladder contraction and refilling function were impaired in subgroups of the gallstone patients. Changes of plasma FGF-19 level may reflect the abnormalities of gallbladder contraction and refilling.
出处 《外科理论与实践》 2012年第3期252-256,共5页 Journal of Surgery Concepts & Practice
基金 国家自然科学基金(81070367 30700310)
关键词 成纤维细胞生长因子-19 胆囊收缩舒张 胆囊结石病 胆囊容积 Fibroblast growth factor-19 Gallbladder contraction and refilling Cholelithiasis Gallbladder volume
  • 相关文献

参考文献3

二级参考文献37

  • 1Portincasa P, Di Ciaula A, Wang HH, et al. Coordinateregulation of gallbladder motor function in the gut-liver axis[J]. Hepatology,2008,47(6):2112-2126.
  • 2Choi M, Moschetta A, Bookout AL, et al. Identification of a hormonal basis for gallbladder filling[J]. Nat Med,2006, 12(11):1253-1255.
  • 3Dodds WJ, Groh WJ, Darweesh RM, et al. Sonographic measurement of gallbladder volume[J]. Am J Roentgenol, 1985,145(5): 1009-1011.
  • 4Jiang ZY, Parini P, Eggertsen G, et al. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients[J]. J Lipid Res,2008,49(2):464-472.
  • 5Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis[J]. Cell Metab,2005,2(4):217-225.
  • 6Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy[J]. Nat Rev Drug Discov, 2009,8(3):235-253.
  • 7Kurosu H, Choi M, Ogawa Y, et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity ofFGF19 and FGF21[J]. J Biol Chem,2007,282(37):26687- 26695.
  • 8Xie MH, Holcomb I, Deuel B, et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4 [J]. Cytokine,1999,11(10):729-735.
  • 9Schaap FG, van der Gaag NA, Gouma D J, et al. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis[J]. Hepatology,2009,49(4): 1228-1235.
  • 10Lundasen T, Galman C, Angelin B, et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man[J]. J Intern Med,2006,260(6):530-536.

共引文献83

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部